ADIAL PHARMACEUTICALS INC (ADIL) Institutional Ownership Changes & 13F Activity
ADIAL PHARMACEUTICALS INC (ADIL). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Jane Street Group, Llc, Citadel Advisors Llc, Stonex Group Inc., Ubs Group Ag, and Geode Capital Management, Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Buy | +29,547 | — | 29,547 | $75.64K | Q2 2026 | Sep 02, 2026 |
| Jane Street Group, Llc | Buy | +32,119 | — | 32,119 | $82.22K | Q2 2026 | Aug 14, 2026 |
| Ubs Group Ag | Buy | +18,605 | +3432.7% | 19,147 | $49.02K | Q2 2026 | Aug 13, 2026 |
| Vanguard Capital Management Llc | Buy | +5,470 | +1515.2% | 5,831 | $14.93K | Q2 2026 | Aug 13, 2026 |
| Stonex Group Inc. | Buy | +19,699 | — | 19,699 | $35.67K | Q2 2026 | Aug 12, 2026 |
| Geode Capital Management, Llc | Sell | -11,856 | -48.9% | 12,393 | $31.73K | Q2 2026 | Aug 12, 2026 |
| Tower Research Capital Llc (Trc) | Buy | +63 | +4.6% | 1,419 | $3.63K | Q2 2026 | Aug 11, 2026 |
| Blackrock, Inc. | Sell | -806 | -72.6% | 304 | $778.00 | Q2 2026 | Aug 07, 2026 |
| China Universal Asset Management Co., Ltd. | Buy | +8,000 | — | 8,000 | $20.48K | Q2 2026 | Jul 24, 2026 |
| Caitong International Asset Management Co., Ltd | Sell | -15 | -100.0% | 0 | $0.00 | Q2 2026 | May 11, 2026 |
| Northwestern Mutual Wealth Management Co | Sell | -4 | -100.0% | 0 | $0.00 | Q2 2026 | May 07, 2026 |
Frequently asked questions about ADIL activity
Which institutional owners are buying ADIL?
Institutional owners buying ADIL include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in ADIL activity?
"Buy" means an investor increased their reported position in ADIL compared to the prior reporting period. This reflects growing exposure to ADIAL PHARMACEUTICALS INC (ADIL) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in ADIL increasing?
Institutional interest in ADIL can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related ADIL Institutional Insights
- ADIL Overview
- ADIL 13F Institutional Holders
- ADIL Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- ADIL Insider Trading & SEC Form 4 Activity
- ADIL Articles
- Top Institutional Investor Stock Rankings